Detalhe da pesquisa
1.
KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
J Immunol
; 209(2): 379-390, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768150
2.
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.
Leukemia
; 37(10): 2036-2049, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528310
3.
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.
Vaccines (Basel)
; 10(12)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560403